ORIGINAL RESEARCH
Published on 06 Jun 2025
Safety and efficacy of sintilimab versus pembrolizumab in the treatment of advanced or recurrent pediatric malignancies: a real-world study in China
doi 10.3389/fimmu.2025.1608844
- 490 views
12
Total downloads
817
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: